| Pharmaceutical active ingredients: |
| Pheniramine MaleatePhenylpropanolamine HydrochloridePyrilamine Maleate |
| Available forms, composition and doses of Triaminic Time Release: |
| Tablets, Extended Release; Oral; Pheniramine Maleate 25 mg; Phenylpropanolamine Hydrochloride 50 mg; Pyrilamine Maleate 25 mg |
| Triaminic Time Release medical category: |
| Human:Antihistamines first generationPropylamine derivativesSympathomimetic (adrenergic) agents |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| R01BA51 - Phenylpropanolamine, combinationsR06AB05 - PheniramineR06AC01 - Mepyramine |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Novartis |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Trihist-D | Pheniramine Maleate; Phenylpropanolamine Hydrochloride; Phenyltoloxamine Citrate; Pyrilamine Maleate | Cypress Pharmaceutical |
| Triatussic | Pheniramine Maleate; Phenylpropanolamine Hydrochloride; Pholcodine; Pyrilamine Maleate; Sodium Benzoate; Sulfogaiacol | Novartis |
| Triaminic Drops | Pheniramine Maleate; Phenylpropanolamine Hydrochloride; Pyrilamine Maleate | Novartis; Wander |
| Triaminic Oral Infant | Pheniramine Maleate; Phenylpropanolamine Hydrochloride; Pyrilamine Maleate | Novartis |
| Triaminic SR | Pheniramine Maleate; Phenylpropanolamine Hydrochloride; Pyrilamine Maleate | Novartis; Sandoz |
| Triaminicol | Pheniramine Maleate; Phenylpropanolamine Hydrochloride; Pyrilamine Maleate | Novartis; Sandoz |
| Tri-P | Pheniramine Maleate; Phenylpropanolamine Hydrochloride; Pyrilamine Maleate | Cypress Pharmaceutical |
| Trisulfaminic | Pheniramine Maleate; Phenylpropanolamine Hydrochloride; Pyrilamine Maleate; Sulfadiazine; Sulfamerazine; Sulfamethazine | Shepherd Pharmaceuticals |
| Poly-Histine | Pheniramine Maleate; Phenyltoloxamine Citrate; Pyrilamine Maleate | Sanofi-Aventis |
| Stillergy | Pheniramine Maleate; Tetrahydrozoline Hydrochloride | Angelini |